Achieve Life Sciences (ACHV) Stock Insights

ACHV price $6.71 -0.22 -3.21%

Ticker
ACHV
Price
$6.71
Change
-0.22 -3.21%
Market cap ?
$690.22M
Beta ?
2.31
Sector
Healthcare
Industry
Biotechnology

Fair value

ACHV fair value $2.20. Price $6.71. Price is 205% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.24M. Growth 13.97%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 102.90M. Net debt -5.97M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ACHV

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.20—10.65M
2026-08-11-0.80-0.16——
2026-05-12-0.19-0.30——
2026-03-24-0.28-0.27——
2025-11-06-0.28-0.24——
2025-08-07-0.37-0.37——
2025-05-13-0.37-0.37——
2025-03-11-0.36-0.30——
2024-11-07-0.36-0.26——
2024-08-13-0.25-0.22——
2024-05-09-0.26-0.24——
2024-03-28-0.26-0.32——
2023-11-09-0.34-0.34——
2023-08-14-0.43-0.41——
2023-05-09-0.50-0.65——
2023-03-16-0.83-0.90—100.00K
2022-11-14-1.35-1.10—62.50K
2022-08-11-1.08-0.79—62.50K
2022-05-12-0.80-0.82——
2022-03-10-0.76-0.73—50.00K
2021-11-09-0.71-1.09——
2021-08-11-1.53-1.23——
2021-05-13-1.30-0.78——
2021-03-11-1.11-1.27——
2020-11-12-1.14-1.30——
2020-08-06-1.68-3.80——
2020-05-14-2.20-2.40——
2020-03-13-6.00-5.40——
2019-11-06-9.00-4.40——
2019-08-08-10.00-6.60——
2019-05-15-17.60-12.60——
2019-03-14-11.00-12.80——
2018-11-07-14.20-25.60——
2018-08-08-36.40———
2018-05-09-48.00———
2018-03-01-64.00———
2017-11-09-180.00———
2017-07-31-219.03———
2017-05-15-239.03———
2017-02-23-428.18———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-05Halladay BenjaminBuy200.00K$7.011.40M
2026-10-05Halladay BenjaminBuy200.00K——
2026-10-05Halladay BenjaminOther0——
2026-08-19Stewart Richard AlistairSell20.63K$8.49175.18K
2026-07-27Sellig ThomasBuy25.00K$6.18154.50K
2026-07-27Sellig ThomasBuy16.70K——
2026-07-27Martin Christopher NathanBuy25.00K$6.18154.50K
2026-07-27Martin Christopher NathanBuy16.70K——
2026-07-27Royston AaronBuy25.00K$6.18154.50K
2026-07-27Royston AaronBuy16.70K——
2026-07-27Waldman Reid AlexanderBuy25.00K$6.18154.50K
2026-07-27Waldman Reid AlexanderBuy16.70K——
2026-07-27Stewart Richard AlistairBuy25.00K$6.18154.50K
2026-07-27Stewart Richard AlistairBuy16.70K——
2026-07-27Farrow Jeffrey SBuy25.00K$6.18154.50K
2026-07-27Farrow Jeffrey SBuy16.70K——
2026-07-27Phelan Nancy R.Buy25.00K$6.18154.50K
2026-07-27Phelan Nancy R.Buy16.70K——
2026-05-29Waldman Reid AlexanderBuy47.25K$5.24247.59K
2026-05-29Farrow Jeffrey SBuy47.25K$5.24247.59K
2026-05-29Waldman Reid AlexanderOther0——
2026-05-29Farrow Jeffrey SOther0——
2026-05-11Martin Christopher NathanBuy47.25K$5.59264.13K
2026-05-11Martin Christopher NathanOther0——
2026-04-18Goldberg Andrew D.Buy11.71M——
2026-04-18Goldberg Andrew D.Buy3.60M$4.2515.31M
2026-04-18Goldberg Andrew D.Buy1.80M——
2026-04-18Goldberg Andrew D.Other0——
2026-04-17Royston AaronOther0——
2026-04-17TPG GP A, LLCOther0——
2026-04-17TPG GP A, LLCOther6.88M$3.5124.14M
2026-04-17Iancovici LucianOther0——
2026-01-28Rubinstein Mark LawrenceBuy180.00K$4.36784.80K
2026-01-28Oki Mark KBuy180.00K$4.36784.80K
2026-01-28Xinos JaimeBuy180.00K$4.36784.80K
2026-01-28Donnelly CraigBuy180.00K$4.36784.80K
2026-01-28Stewart Richard AlistairBuy645.00K$4.362.81M
2026-01-28Wan JerryBuy70.30K$4.36306.51K
2026-01-01Rubinstein Mark LawrenceOther0——
2026-01-01Rubinstein Mark LawrenceOther47.00K$4.52212.44K
2026-01-01Rubinstein Mark LawrenceOther50.00K$3.10155.00K
2025-12-04Atkisson ErikBuy250.00K$4.781.20M
2025-10-20Atkisson ErikOther0——
2025-10-01Donnelly CraigBuy50.00K$3.10155.00K
2025-09-18Oki Mark KBuy168.00K——
2025-09-18Oki Mark KSell50.06K$2.92146.18K
2025-09-18Oki Mark KSell168.00K——
2025-09-18Stewart Richard AlistairBuy297.50K——
2025-09-18Stewart Richard AlistairSell129.50K$2.92378.14K
2025-09-18Stewart Richard AlistairSell157.50K——
2025-09-08Donnelly CraigOther0——
2025-09-08Donnelly CraigOther22.50K$4.55102.38K
2025-09-08Donnelly CraigOther25.00K$4.53113.25K
2025-09-04Oki Mark KSell168.00K——
2025-09-04Stewart Richard AlistairSell157.50K——
2025-09-04Wan JerryBuy34.10K——
2025-09-04Wan JerrySell9.60K——
2025-09-04Wan JerrySell14.07K$2.7738.97K
2025-09-04Wan JerrySell24.50K——
2025-09-04KING THOMAS BRAXTONBuy455.00K——
2025-09-04KING THOMAS BRAXTONSell139.86K$2.77387.41K
2025-09-04KING THOMAS BRAXTONSell455.00K——
2025-09-04JACOBS CINDYBuy110.00K——
2025-09-04JACOBS CINDYSell27.63K$2.7776.53K
2025-09-04JACOBS CINDYSell26.00K——
2025-09-04JACOBS CINDYSell84.00K——
2025-09-04Xinos JaimeBuy69.00K——
2025-09-04Xinos JaimeSell20.00K——
2025-09-04Xinos JaimeSell20.85K$2.7757.77K
2025-09-04Xinos JaimeSell49.00K——
2025-06-06Slaoui Kristen B.Buy31.50K$3.83120.64K
2025-06-06Phelan Nancy R.Buy31.50K$3.83120.64K
2025-06-06Sellig ThomasBuy31.50K$3.83120.64K
2025-06-06Martell Bridget ABuy31.50K$3.83120.64K
2025-06-06KING THOMAS BRAXTONBuy31.50K$3.83120.64K
2025-06-06Duty StuartBuy31.50K$3.83120.64K
2025-03-17Oki Mark KBuy10.00K$2.8928.89K
2025-03-17Stewart Richard AlistairBuy10.00K$2.8628.60K
2025-01-28Wan JerryBuy48.00K——
2025-01-28Xinos JaimeBuy100.00K——
2025-01-28JACOBS CINDYBuy130.00K——
2025-01-13Slaoui Kristen B.Buy47.25K$3.32156.87K
2025-01-13Phelan Nancy R.Buy47.25K$3.32156.87K
2025-01-13Stewart Richard AlistairBuy157.50K——
2025-01-13Stewart Richard AlistairBuy67.50K$3.32224.10K
2025-01-13KING THOMAS BRAXTONBuy455.00K——
2025-01-13KING THOMAS BRAXTONBuy195.00K$3.32647.40K
2025-01-13Xinos JaimeBuy20.00K$3.3266.40K
2025-01-06Slaoui Kristen B.Other0——
2025-01-06Phelan Nancy R.Other0——
2024-12-06Xinos JaimeBuy30.00K$4.52135.60K
2024-12-06Oki Mark KBuy168.00K——
2024-12-06Oki Mark KBuy72.00K$4.52325.44K
2024-12-05Oki Mark KOther0——
2024-10-15Xinos JaimeOther0——
2024-10-15Xinos JaimeOther1.00K$67.4067.40K
2024-10-15Xinos JaimeOther10.00K$11.20112.00K
2024-10-15Xinos JaimeOther22.50K$8.26185.85K
2024-10-15Xinos JaimeOther2.00K$28.4056.80K
2024-10-15Xinos JaimeOther32.50K$4.90159.25K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 119, holders +33 vs prior quarter. Ownership 88.57%.

HolderSharesChangeChange %Value
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.7.61M7.61MNew49.72M
TPG GP A, LLC6.88M6.88MNew44.91M
VENBIO PARTNERS LLC5.91M5.91MNew38.62M
LOGOS GLOBAL MANAGEMENT LP5.42M5.42MNew35.43M
BLACKROCK, INC.5.27M4.83M+1099.93%34.43M
FRANKLIN TEMPLETON INC4.95M584.03K+13.37%32.34M
PARADIGM BIOCAPITAL ADVISORS LP4.95M4.95MNew32.34M
VANGUARD CAPITAL MANAGEMENT LLC4.14M1.94M+87.82%27.04M
PROPEL BIO MANAGEMENT, LLC4.03M247.59K+6.54%26.34M
MARSHALL WACE, LLP3.77M2.75M+269.90%24.62M
STATE STREET CORP2.95M2.69M+1057.57%19.23M
VIVO CAPITAL, LLC2.75M2.75MNew17.96M
JUPITER TOPCO LLC2.75M2.75MNew17.96M
VENROCK ADVISER, LLC2.75M2.75MNew17.96M
EVENTIDE ASSET MANAGEMENT, LLC2.22M2.22MNew14.50M
GEODE CAPITAL MANAGEMENT, LLC2.06M1.44M+231.21%13.47M
ALYESKA INVESTMENT GROUP, L.P.1.93M1.93MNew12.57M
SIMPLIFY ASSET MANAGEMENT INC.1.43M247.59K+20.90%9.35M
WELLINGTON MANAGEMENT GROUP LLP1.43M1.43MNew9.32M
CAPTION MANAGEMENT, LLC1.18M1.18M+851711.59%7.68M
LPL FINANCIAL LLC902.25K173.81K+23.86%5.89M
NORTHERN TRUST CORP743.76K519.02K+230.94%4.86M
SPRUCE STREET CAPITAL LP736.64K736.64KNew4.81M
VANGUARD FIDUCIARY TRUST CO593.75K277.57K+87.79%3.88M
SUSQUEHANNA INTERNATIONAL GROUP, LLP577.50K535.20K+1265.25%3.77M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Achieve Life Sciences (ACHV) Stock Insights

ACHV$6.71-0.22 -3.21%

$690.22M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History